The New England journal of medicine, 2019-10, Vol.381 (17), p.1609-1620
- Solomon, Scott D
- McMurray, John J.V
- Anand, Inder S
- Ge, Junbo
- Lam, Carolyn S.P
- Maggioni, Aldo P
- Martinez, Felipe
- Packer, Milton
- Pfeffer, Marc A
- Pieske, Burkert
- Redfield, Margaret M
- Rouleau, Jean L
- van Veldhuisen, Dirk J
- Zannad, Faiez
- Zile, Michael R
- Desai, Akshay S
- Claggett, Brian
- Jhund, Pardeep S
- Boytsov, Sergey A
- Comin-Colet, Josep
- Cleland, John
- Düngen, Hans-Dirk
- Goncalvesova, Eva
- Katova, Tzvetana
- Kerr Saraiva, Jose F
- Lelonek, Małgorzata
- Merkely, Bela
- Senni, Michele
- Shah, Sanjiv J
- Zhou, Jingmin
- Rizkala, Adel R
- Gong, Jianjian
- Shi, Victor C
- Lefkowitz, Martin P
2019
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Solomon, Scott D
- McMurray, John J.V
- Anand, Inder S
- Ge, Junbo
- Lam, Carolyn S.P
- Maggioni, Aldo P
- Martinez, Felipe
- Packer, Milton
- Pfeffer, Marc A
- Pieske, Burkert
- Redfield, Margaret M
- Rouleau, Jean L
- van Veldhuisen, Dirk J
- Zannad, Faiez
- Zile, Michael R
- Desai, Akshay S
- Claggett, Brian
- Jhund, Pardeep S
- Boytsov, Sergey A
- Comin-Colet, Josep
- Cleland, John
- Düngen, Hans-Dirk
- Goncalvesova, Eva
- Katova, Tzvetana
- Kerr Saraiva, Jose F
- Lelonek, Małgorzata
- Merkely, Bela
- Senni, Michele
- Shah, Sanjiv J
- Zhou, Jingmin
- Rizkala, Adel R
- Gong, Jianjian
- Shi, Victor C
- Lefkowitz, Martin P
- Titel
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- Ist Teil von
- The New England journal of medicine, 2019-10, Vol.381 (17), p.1609-1620
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2019
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Patients with heart failure with preserved ejection fraction were assigned to receive sacubitril–valsartan or valsartan. At a median of 35 months, there was no significant between-group difference in the composite outcome of total hospitalizations for heart failure or death from cardiovascular causes.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa1908655Titel-ID: cdi_proquest_journals_2308228989
- Format
- –
- Schlagworte
- Aged, Aminobutyrates - administration & dosage, Aminobutyrates - adverse effects, Angioedema, Angioedema - chemically induced, Angiotensin, Angiotensin Receptor Antagonists - administration & dosage, Angiotensin Receptor Antagonists - adverse effects, Cardiomyopathy, Cardiovascular Diseases - mortality, Clinical trials, Congestive heart failure, Coronary artery disease, Death, Double-Blind Method, Drug Combinations, Ejection fraction, Female, Follow-Up Studies, Heart failure, Heart Failure - drug therapy, Heart Failure - physiopathology, Heart rate, Hospitalization, Hospitalization - statistics & numerical data, Humans, Hyperkalemia, Hypotension, Hypotension - chemically induced, Male, Middle Aged, Mortality, Neprilysin, Neprilysin - antagonists & inhibitors, Patient safety, Pharmaceuticals, Quality of Life, Renal function, Sex Factors, Single-Blind Method, Stroke Volume, Tetrazoles - administration & dosage, Tetrazoles - adverse effects, Valsartan - administration & dosage, Valsartan - adverse effects